STOCK TITAN

WuXi AppTec Earns SBTi Validation for Near-Term Emissions Reduction Targets

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags
WuXi AppTec (WUXAY) has received validation from the Science Based Targets initiative (SBTi) for its near-term emissions reduction targets, demonstrating alignment with global efforts to limit temperature rise to 1.5°C. The company commits to reducing absolute Scope 1 and 2 GHG emissions by 42% by 2030 from 2024 levels, and Scope 3 emissions from purchased goods and services by 25%. To achieve these targets, WuXi AppTec is implementing various measures including process optimization, equipment upgrades, infrastructure renovation, and increasing renewable energy usage. The company has garnered multiple sustainability recognitions, including an AA rating in MSCI ESG ratings, inclusion in the Dow Jones Sustainability Index, and an A- Leadership rating in CDP Climate Change rating. As a global provider of R&D and manufacturing services for pharmaceutical and life science industries, WuXi AppTec has also joined the UN Global Compact and Pharmaceutical Supply Chain Initiative.
WuXi AppTec (WUXAY) ha ottenuto la convalida dall'iniziativa Science Based Targets (SBTi) per i suoi obiettivi di riduzione delle emissioni a breve termine, dimostrando l'allineamento con gli sforzi globali per limitare l'aumento della temperatura a 1,5°C. L'azienda si impegna a ridurre le emissioni assolute di gas serra Scope 1 e 2 del 42% entro il 2030 rispetto ai livelli del 2024, e le emissioni Scope 3 derivanti da beni e servizi acquistati del 25%. Per raggiungere questi obiettivi, WuXi AppTec sta attuando diverse misure, tra cui l'ottimizzazione dei processi, l'aggiornamento delle attrezzature, la ristrutturazione delle infrastrutture e l'aumento dell'uso di energie rinnovabili. L'azienda ha ricevuto numerosi riconoscimenti per la sostenibilità, tra cui una valutazione AA nelle MSCI ESG ratings, l'inclusione nel Dow Jones Sustainability Index e una valutazione di leadership A- nel CDP Climate Change rating. In qualità di fornitore globale di servizi di R&D e produzione per l'industria farmaceutica e delle scienze della vita, WuXi AppTec ha inoltre aderito al Global Compact delle Nazioni Unite e all'Initiative della catena di fornitura farmaceutica.
WuXi AppTec (WUXAY) ha recibido la validación de la iniciativa Science Based Targets (SBTi) para sus objetivos de reducción de emisiones a corto plazo, demostrando su alineación con los esfuerzos globales para limitar el aumento de la temperatura a 1,5°C. La compañía se compromete a reducir las emisiones absolutas de gases de efecto invernadero de Alcance 1 y 2 en un 42% para 2030 respecto a los niveles de 2024, y las emisiones de Alcance 3 provenientes de bienes y servicios adquiridos en un 25%. Para alcanzar estos objetivos, WuXi AppTec está implementando diversas medidas, incluyendo la optimización de procesos, actualización de equipos, renovación de infraestructuras y aumento del uso de energía renovable. La empresa ha recibido múltiples reconocimientos en sostenibilidad, incluyendo una calificación AA en MSCI ESG ratings, inclusión en el Dow Jones Sustainability Index y una calificación de liderazgo A- en el CDP Climate Change rating. Como proveedor global de servicios de I+D y fabricación para las industrias farmacéutica y de ciencias de la vida, WuXi AppTec también se ha unido al Pacto Mundial de la ONU y a la Iniciativa de la Cadena de Suministro Farmacéutica.
WuXi AppTec (WUXAY)는 Science Based Targets initiative(SBTi)로부터 단기 배출 감축 목표에 대한 검증을 받았으며, 이는 지구 온도 상승을 1.5°C로 제한하려는 전 세계적 노력과의 일치를 보여줍니다. 회사는 2024년 대비 2030년까지 절대 Scope 1 및 2 온실가스 배출량을 42% 감축하고, 구매한 상품 및 서비스에서 발생하는 Scope 3 배출량을 25% 감축할 것을 약속합니다. 이러한 목표 달성을 위해 WuXi AppTec는 공정 최적화, 장비 업그레이드, 인프라 개조, 재생 에너지 사용 확대 등 다양한 조치를 시행하고 있습니다. 회사는 MSCI ESG 평가에서 AA 등급, 다우존스 지속가능성 지수 포함, CDP 기후 변화 평가에서 A- 리더십 등급 등 여러 지속 가능성 인정을 받았습니다. 제약 및 생명과학 산업을 위한 글로벌 연구개발 및 제조 서비스 제공업체로서 WuXi AppTec는 유엔 글로벌 콤팩트와 제약 공급망 이니셔티브에도 참여하고 있습니다.
WuXi AppTec (WUXAY) a obtenu la validation de l’initiative Science Based Targets (SBTi) pour ses objectifs de réduction des émissions à court terme, démontrant son alignement avec les efforts mondiaux visant à limiter le réchauffement climatique à 1,5°C. L’entreprise s’engage à réduire de 42 % ses émissions absolues de gaz à effet de serre des scopes 1 et 2 d’ici 2030 par rapport aux niveaux de 2024, ainsi qu’à diminuer de 25 % ses émissions du scope 3 liées aux biens et services achetés. Pour atteindre ces objectifs, WuXi AppTec met en œuvre diverses mesures, notamment l’optimisation des processus, la modernisation des équipements, la rénovation des infrastructures et l’augmentation de l’utilisation des énergies renouvelables. La société a reçu plusieurs reconnaissances en matière de durabilité, dont une note AA dans les évaluations ESG de MSCI, son inclusion dans le Dow Jones Sustainability Index et une note de leadership A- dans l’évaluation CDP sur le changement climatique. En tant que fournisseur mondial de services de R&D et de fabrication pour les industries pharmaceutiques et des sciences de la vie, WuXi AppTec a également rejoint le Pacte mondial des Nations Unies et l’Initiative de la chaîne d’approvisionnement pharmaceutique.
WuXi AppTec (WUXAY) hat von der Science Based Targets Initiative (SBTi) eine Validierung für seine kurzfristigen Emissionsreduktionsziele erhalten, was die Übereinstimmung mit den globalen Bemühungen zur Begrenzung des Temperaturanstiegs auf 1,5 °C zeigt. Das Unternehmen verpflichtet sich, die absoluten Treibhausgasemissionen der Scope 1 und 2 bis 2030 um 42 % gegenüber dem Niveau von 2024 zu reduzieren und die Scope-3-Emissionen aus eingekauften Waren und Dienstleistungen um 25 %. Um diese Ziele zu erreichen, setzt WuXi AppTec verschiedene Maßnahmen um, darunter Prozessoptimierung, Geräteaufrüstung, Infrastrukturrenovierung und eine verstärkte Nutzung erneuerbarer Energien. Das Unternehmen hat mehrere Nachhaltigkeitsanerkennungen erhalten, darunter eine AA-Bewertung im MSCI ESG-Rating, die Aufnahme in den Dow Jones Sustainability Index und eine A- Leadership-Bewertung im CDP Climate Change Rating. Als globaler Anbieter von F&E- und Fertigungsdienstleistungen für die Pharma- und Life-Science-Branche ist WuXi AppTec auch dem UN Global Compact und der Pharmaceutical Supply Chain Initiative beigetreten.
Positive
  • Ambitious commitment to reduce Scope 1 and 2 GHG emissions by 42% by 2030
  • Strong environmental credentials with AA MSCI ESG rating and inclusion in DJSI
  • Implementation of concrete measures for emissions reduction including renewable energy adoption
  • Strategic partnerships through UN Global Compact and PSCI membership
Negative
  • None.

SHANGHAI, June 17, 2025 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, announced that the Science Based Targets initiative (SBTi) has approved WuXi AppTec's near-term science-based emissions reduction targets. The validation of these targets affirms that the Company's planned reduction in greenhouse gas (GHG) emissions aligns with the goal of limiting global temperature rise to 1.5°C, underscoring WuXi AppTec's commitment to meaningful action for a more sustainable future.

With the SBTi validation, WuXi AppTec commits to reducing absolute Scope 1 and 2 GHG emissions by 42% by 2030, based on 2024 levels. The Company also aims to reduce absolute Scope 3 GHG emissions from purchased goods and services and fuel- and energy-related activities by 25% within the same timeframe (Scopes 1, 2, 3 are internationally recognized ways of classifying greenhouse gas emissions).

The SBTi enables companies and financial institutions worldwide to play a pivotal role in combating the climate crisis. It develops standards, tools, and guidance that enable organizations to set GHG emissions reduction targets in line with what is required to keep global heating below catastrophic levels and achieve net-zero by 2050.

"SBTi validation of WuXi AppTec's near-term targets marks an important milestone in our Company's sustainability journey," said Dr. Steve Yang, Co-CEO of WuXi AppTec and Chairman of WuXi AppTec's ESG Committee. "This recognition underscores our commitment to corporate social responsibility, scientific rigor, and transparency of our greenhouse gas emission reduction efforts. WuXi AppTec is dedicated to supporting our customers in delivering innovative therapies to patients worldwide, working together toward a healthier and more sustainable future."

To achieve these targets, WuXi AppTec is implementing measures such as process optimization, equipment upgrades, infrastructure renovation, and technological innovations to enhance energy efficiency. The Company is also increasing its use of renewable energy by purchasing green electricity and installing photovoltaic power generation facilities. These efforts aim to progressively reduce carbon emissions within operational boundaries. Furthermore, WuXi AppTec is collaborating with suppliers to reduce absolute GHG emissions associated with purchased goods and services, fostering progress toward a low-carbon supply chain.

As an enabler of innovation, a trusted partner, and a contributor to the global pharmaceutical and life sciences industry, WuXi AppTec strategically integrates sustainability priorities like most of the customers into its global business operations. The Company has received an AA rating in the MSCI ESG ratings for four consecutive years, inclusion in the Dow Jones Sustainability Index (DJSI) for the same duration, and an A- Leadership rating in the CDP Climate Change rating for three consecutive years. WuXi AppTec has also been recognized as an Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics and received an A Leadership rating in the CDP Water Security rating, as well as a Gold Medal in the EcoVadis sustainability rating.

To further its commitment to sustainability, WuXi AppTec has joined the United Nations Global Compact (UNGC) and the Pharmaceutical Supply Chain Initiative (PSCI) as a supplier partner.

About WuXi AppTec

As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec's integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received an AA ESG rating from MSCI for the fourth consecutive year in 2024 and its open-access platform is enabling around 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated."

Cision View original content:https://www.prnewswire.com/news-releases/wuxi-apptec-earns-sbti-validation-for-near-term-emissions-reduction-targets-302483559.html

SOURCE WuXi AppTec

FAQ

What are WuXi AppTec's (WUXAY) emissions reduction targets for 2030?

WuXi AppTec commits to reducing absolute Scope 1 and 2 GHG emissions by 42% and Scope 3 emissions from purchased goods and services by 25% by 2030, based on 2024 levels.

How is WuXi AppTec (WUXAY) planning to achieve its emissions reduction goals?

The company is implementing process optimization, equipment upgrades, infrastructure renovation, increasing renewable energy usage through green electricity purchases, and installing photovoltaic power generation facilities.

What sustainability recognitions has WuXi AppTec (WUXAY) received?

The company has received an AA rating in MSCI ESG ratings for four consecutive years, inclusion in the Dow Jones Sustainability Index, an A- Leadership rating in CDP Climate Change, and a Gold Medal in EcoVadis sustainability rating.

What is the significance of SBTi validation for WuXi AppTec (WUXAY)?

SBTi validation confirms that WuXi AppTec's emissions reduction targets align with global efforts to limit temperature rise to 1.5°C, demonstrating the company's commitment to meaningful climate action.
Wuxi Apptec

OTC:WUXAY

WUXAY Rankings

WUXAY Latest News

WUXAY Stock Data

27.85B
2.50B
Diagnostics & Research
Healthcare
Link
China
Shanghai